GENERATION AND CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS

被引:87
|
作者
ADACHI, A [1 ]
ONO, N [1 ]
SAKAI, H [1 ]
OGAWA, K [1 ]
SHIBATA, R [1 ]
KIYOMASU, T [1 ]
MASUIKE, H [1 ]
UEDA, S [1 ]
机构
[1] OSAKA UNIV,MICROBIAL DIS RES INST,OSAKA,JAPAN
关键词
D O I
10.1007/BF01310491
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mutations were introduced by recombinant DNA techniques into 9 genes of an infectious molecular clone of human immunodeficiency virus type 1. The 24 mutants generated were characterized biochemically and biologically by transfection and infection experiments. None of the mutants which have mutations in gag (p17,p24, and p15 regions), pol(protease, reverse transcriptase, and endonuclease domains), env (gp120 region), tat, or rev were infectious, whereas vif, vpr, vpu, some of env (gp41) and nef mutants could grow in human CD4+ cells to various degrees. Of the non-infectious mutants, only endonuclease (pol) and gp41 mutants exhibited normal phenotypes with respect to the production of functional reverse transcriptase, the expression of gag, pol, and env proteins, and the generation of progeny virions, when examined in transient assays. All infectious mutants killed the CD4+ cells with the exception of a mutant carrying a defect in the vif gene.
引用
收藏
页码:45 / 58
页数:14
相关论文
共 50 条
  • [31] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY OZONE INVITRO
    WELLS, KH
    LATINO, J
    GAVALCHIN, J
    POIESZ, BJ
    BLOOD, 1991, 78 (07) : 1882 - 1890
  • [32] ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    COLL, J
    YAZBECK, H
    GUTIERREZ, J
    MEDICINA CLINICA, 1993, 100 (09): : 357 - 358
  • [33] BIOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 MUTANTS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    AKARI, H
    SAKURAGI, J
    TAKEBE, Y
    TOMONAGA, K
    KAWAMURA, M
    FUKASAWA, M
    MIURA, T
    SHINJO, T
    HAYAMI, M
    ARCHIVES OF VIROLOGY, 1992, 123 (1-2) : 157 - 167
  • [34] THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CAPUTO, A
    GROSSI, MP
    ROSSI, C
    CAMPIONI, D
    BALBONI, PG
    CORALLINI, A
    BARBANTIBRODANO, G
    MICROBIOLOGICA, 1995, 18 (01): : 87 - 110
  • [35] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE BY CURCUMIN
    MAZUMDER, A
    RAGHAVAN, K
    WEINSTEIN, J
    KOHN, KW
    POMMIER, Y
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (08) : 1165 - 1170
  • [36] CURRENT STATUS OF THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LANE, HC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 486 - 489
  • [37] INTEGRATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) : 4164 - 4168
  • [38] CIRCULARIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1991, 65 (12) : 6942 - 6952
  • [39] HYDROXYCHLOROQUINE TREATMENT OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SPERBER, K
    LOUIE, M
    KRAUS, T
    PRONER, J
    SAPIRA, E
    LIN, S
    STECHER, V
    MAYER, L
    CLINICAL THERAPEUTICS, 1995, 17 (04) : 622 - 636
  • [40] MOLECULAR INSIGHTS INTO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PATHOGENESIS
    FEINBERG, MB
    GREENE, WC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 466 - 474